The administration method of meropenem on the basis of PK/PD (pharmacokinetics/pharmacodynamics) in consideration of renal function

Japanese Journal of Antibiotics

Volumn 59, Issue 6, 2006, Pages 459-467

  Mikamo, Hiroshige ^a,b   Tanaka, Kaori ^a   Watanabe, Kunitomo ^a  

^a GIFU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MEROPENEM;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG MECHANISM; HUMAN; KIDNEY FUNCTION; MINIMUM INHIBITORY CONCENTRATION; PERITONITIS; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CREATININE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MIDDLE AGED; PERITONITIS; THIENAMYCINS;

EID: 33846794874     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. CRAIG, W. A.: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26: 1-12, 1998
2. KUTI, J. L.; P. K. DANDEKAR, C. H. NIGHTINGALE & D. P. NICOLAU: Use of Monte Carlo Simulation to design an optimized pharmacodynamic dosing strategy for meropenem. J. Clin. Pharmacol. 43: 1116-1123, 2003
3. Japanese source
4. Jpn. J. Antibiotics 58 : 159-167, 2005
5. Jpn. J. Antibiotics 58: 359-367, 2005
6. KUTI, J. L.; P. K. DANDEKAR & C. H. NIGHTINGALE: Use of Monte Carlo Simulation to design an optimized pharmacodynamic dosing strategy for meropenem. J. Clin. Pharmacol. 43: 1116-1123, 2003
7. KUTI, J. L.; C. H. NIGHTINGALE & D. P. NICOLAU: Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002. Antimicrob. Agents Chemother. 48: 2464-2476, 2004
8. MOUTON, J. W. & J. N. VAN DEN ANKER: Meropenem clinical pharmacokinetics. Clin. Pharmacokinet. 28: 275-286, 1995
9. KOLLEF, M. H.: Appropriate empirical antibacterial therapy for nosocomial infections. Durgs 63: 2157-2168, 2003
10. Chemotherapy 40(S-1): 145-153, 1992
11. Chemotherapy 40(S-1): 123-131, 1992